glp-1 gip therapy effectiveness muscle preservation 🔬 GLP-1/GIP Discontinuation: Why the “How” Matters One of the most-discussed challenges with GLP-1/GIP agonists such as tirzepatide (Mounjaro®) is weight regain after stopping therapy. What… | Paramesh Shamanna GLP-1/GIP loses superior potency over

The histological benefit is large enough to have changed the regulatory landscape

We recommend using only FDA-approved medications for safety and consistent results

Thus, many Americans have been exposed to the big names of GLP-1 drugs like Ozempic, Wegovy and Zepbound

NHLBI deliciously healthy eating recipes

doi: 10.1210/jcem.86.9.7814 186 BedogniGGrugniGTringaliGMarazziNSartorioA

Safety concerns were also raised in a phase 1 trial investigating the GLP-1R/GCGR agonist NNC9204-117, where a dose-dependent increase in heart rate was observed, in addition to increased markers of inflammation, hepatic disturbances, impaired glucose tolerance, and reduced blood levels of some amino acids despite clinically relevant weight loss (Friedrichsen et al